Chinese Journal of Antituberculosis ›› 2022, Vol. 44 ›› Issue (5): 500-504.doi: 10.19982/j.issn.1000-6621.20210582
• Review Articles • Previous Articles Next Articles
FEI Wan-wan, LU Zhen-hui, HUANG Xing, LI Cui, ZHANG Hui-yong, JIANG Yu-wei()
Received:
2021-09-28
Online:
2022-05-10
Published:
2022-05-04
Contact:
JIANG Yu-wei
E-mail:jiangyuwei2020@163.com
Supported by:
CLC Number:
FEI Wan-wan, LU Zhen-hui, HUANG Xing, LI Cui, ZHANG Hui-yong, JIANG Yu-wei. Research progress on the correlation of gut microbiota with and pulmonary tuberculosis based on the theory of exterior and interior of lung and large intestine[J]. Chinese Journal of Antituberculosis, 2022, 44(5): 500-504. doi: 10.19982/j.issn.1000-6621.20210582
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20210582
[1] |
周玲玲. 300例肺结核病患者抗结核药物不良反应的调查分析. 当代医学, 2021, 27(15):159-160. doi: 10.3969/j.issn.1009-4393.2021.15.063.
doi: 10.3969/j.issn.1009-4393.2021.15.063 |
[2] |
杨元利, 张永峰, 窦权利 . 老年肺结核病130例临床分析. 陕西医学杂志, 2019, 48(12): 1691-1693. doi: 10.3969/j.issn.1000-7377.2019.12.032.
doi: 10.3969/j.issn.1000-7377.2019.12.032 |
[3] |
Luo M, Liu Y, Wu P, et al. Alternation of Gut Microbiota in Patients with Pulmonary Tuberculosis. Front Physiol, 2017, 8: 822. doi: 10.3389/fphys.2017.00822.
doi: 10.3389/fphys.2017.00822 URL |
[4] |
Wipperman MF, Fitzgerald DW, Juste MAJ, et al. Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed. Sci Rep, 2017, 7(1): 10767. doi: 10.1038/s41598-017-10346-6.
doi: 10.1038/s41598-017-10346-6 pmid: 28883399 |
[5] |
Namasivayam S, Maiga M, Yuan W, et al. Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy. Microbiome, 2017, 5(1): 71. doi: 10.1186/s40168-017-0286-2.
doi: 10.1186/s40168-017-0286-2 URL |
[6] |
Hu Y, Feng Y, Wu J, et al. The Gut Microbiome Signatures Discriminate Healthy From Pulmonary Tuberculosis Patients. Front Cell Infect Microbiol, 2019, 9: 90. doi: 10.3389/fcimb.2019.00090.
doi: 10.3389/fcimb.2019.00090 URL |
[7] |
Hu Y, Yang Q, Liu B, et al. Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs. J Infect, 2019, 78(4): 317-322. doi: 10.1016/j.jinf.2018.08.006.
doi: 10.1016/j.jinf.2018.08.006 URL |
[8] |
Maji A, Misra R, Dhakan DB, et al. Gut microbiome contribu-tes to impairment of immunity in pulmonary tuberculosis patients by alteration of butyrate and propionate producers. Environ Microbiol, 2018, 20(1): 402-419. doi: 10.1111/1462-2920.14015.
doi: 10.1111/1462-2920.14015 URL |
[9] |
Khan N, Vidyarthi A, Nadeem S, et al. Alteration in the Gut Microbiota Provokes Susceptibility to Tuberculosis. Front Immunol, 2016, 7: 529. doi: 10.3389/fimmu.2016.00529.
doi: 10.3389/fimmu.2016.00529 |
[10] |
Noverr MC, Huffnagle GB. Does the microbiota regulate immune responses outside the gut? Trends Microbiol, 2004, 12(12): 562-568. doi: 10.1016/j.tim.2004.10.008.
doi: 10.1016/j.tim.2004.10.008 pmid: 15539116 |
[11] |
Arnold IC, Hutchings C, Kondova I, et al. Helicobacter hepaticus infection in BALB/c mice abolishes subunit-vaccine-induced protection against M.tuberculosis. Vaccine, 2015, 33(15): 1808-1814. doi: 10.1016/j.vaccine.2015.02.041.
doi: 10.1016/j.vaccine.2015.02.041 URL |
[12] |
Marsland BJ, Trompette A, Gollwitzer ES. The Gut-Lung Axis in Respiratory Disease. Ann Am Thorac Soc, 2015, 12 Suppl 2: S150-S156. doi: 10.1513/AnnalsATS.201503-133AW.
doi: 10.1513/AnnalsATS.201503-133AW |
[13] |
He Y, Wen Q, Yao F, et al. Gut-lung axis: The microbial contributions and clinical implications. Crit Rev Microbiol, 2017, 43(1): 81-95. doi: 10.1080/1040841X.2016.1176988.
doi: 10.1080/1040841X.2016.1176988 URL |
[14] |
McDermott MR, Clark DA, Bienenstock J. Evidence for a common mucosal immunologic system.Ⅱ. Influence of the estrous cycle on B immunoblast migration into genital and intestinal tissues. J Immunol, 1980, 124(6): 2536-2539.
pmid: 6966293 |
[15] | 杜丽娟, 王玲, 李风森. 从哮喘黏膜免疫中T淋巴细胞表达的研究阐释“肺与大肠相表里”理论. 辽宁中医杂志, 2012, 39(8):1620-1622. |
[16] |
Sugawara I, Udagawa T, Yamada H. Rat neutrophils prevent the development of tuberculosis. Infect Immun, 2004, 72(3): 1804-1806. doi: 10.1128/IAI.72.3.1804-1806.2004.
doi: 10.1128/IAI.72.3.1804-1806.2004 pmid: 14977991 |
[17] |
Martineau AR, Newton SM, Wilkinson KA, et al. Neutrophil-mediated innate immune resistance to mycobacteria. J Clin Invest, 2007, 117(7): 1988-1994. doi: 10.1172/JCI31097.
doi: 10.1172/JCI31097 pmid: 17607367 |
[18] |
Clarke TB, Davis KM, Lysenko ES, et al. Recognition of peptidoglycan from the microbiota by Nod 1 enhances systemic innate immunity. Nat Med, 2010, 16(2): 228-231. doi: 10.1038/nm.2087.
doi: 10.1038/nm.2087 URL |
[19] |
Balfour A, Schutz C, Goliath R, et al. Functional and Activation Profiles of Mucosal-Associated Invariant T Cells in Patients With Tuberculosis and HIV in a High Endemic Setting. Front Immunol, 2021, 12: 648216. doi: 10.3389/fimmu.2021.648216.
doi: 10.3389/fimmu.2021.648216 URL |
[20] |
Zhang N, Luo X, Huang J, et al. The landscape of different molecular modules in an immune microenvironment during tuberculosis infection. Brief Bioinform, 2021, 22(5): bbab071. doi: 10.1093/bib/bbab071.
doi: 10.1093/bib/bbab071 URL |
[21] |
Le Bourhis L, Martin E, Péguillet I, et al. Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol, 2010, 11(8): 701-708. doi: 10.1038/ni.1890.
doi: 10.1038/ni.1890 pmid: 20581831 |
[22] |
Dumas A, Corral D, Colom A, et al. The Host Microbiota Contributes to Early Protection Against Lung Colonization by Mycobacterium tuberculosis. Front Immunol, 2018, 9: 2656. doi: 10.3389/fimmu.2018.02656.
doi: 10.3389/fimmu.2018.02656 URL |
[23] |
Flynn JL, Chan J, Lin PL. Macrophages and control of granulomatous inflammation in tuberculosis. Mucosal Immunol, 2011, 4(3): 271-278. doi: 10.1038/mi.2011.14.
doi: 10.1038/mi.2011.14 pmid: 21430653 |
[24] |
Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature, 1998, 392(6673): 245-252. doi: 10.1038/32588.
doi: 10.1038/32588 URL |
[25] |
Negi S, Pahari S, Bashir H, et al. Gut Microbiota Regulates Mincle Mediated Activation of Lung Dendritic Cells to Protect Against Mycobacterium tuberculosis. Front Immunol, 2019, 10: 1142. doi: 10.3389/fimmu.2019.01142.
doi: 10.3389/fimmu.2019.01142 URL |
[26] |
Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol, 1995, 155(3): 1151-1164.
pmid: 7636184 |
[27] |
Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol, 2012, 30: 531-564. doi: 10.1146/annurev.immunol.25.022106.141623.
doi: 10.1146/annurev.immunol.25.022106.141623 pmid: 22224781 |
[28] |
Guyot-Revol V, Innes J A, Hackforth S, et al. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med, 2006, 173(7):803-810. doi: 10.1164/rccm.200508-1294OC.
doi: 10.1164/rccm.200508-1294OC URL |
[29] |
Trompette A, Gollwitzer ES, Yadava K, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med, 2014, 20(2): 159-166. doi: 10.1038/nm.3444.
doi: 10.1038/nm.3444 pmid: 24390308 |
[30] |
Arpaia N, Campbell C, Fan X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature, 2013, 504(7480): 451-455. doi: 10.1038/nature12726.
doi: 10.1038/nature12726 URL |
[31] |
Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A, 2010, 107(27): 12204-12209. doi: 10.1073/pnas.0909122107.
doi: 10.1073/pnas.0909122107 pmid: 20566854 |
[32] |
Negatu DA, Liu JJJ, Zimmerman M, et al. Whole-Cell Screen of Fragment Library Identifies Gut Microbiota Metabolite Indole Propionic Acid as Antitubercular. Antimicrob Agents Chemother, 2018, 62(3): e01571-17. doi: 10.1128/AAC.01571-17.
doi: 10.1128/AAC.01571-17 |
[33] |
Morollo AA, Eck MJ. Structure of the cooperative allosteric anthranilate synthase from Salmonella typhimurium. Nat Struct Biol, 2001, 8(3): 243-247. doi: 10.1038/84988.
doi: 10.1038/84988 pmid: 11224570 |
[34] |
Bashiri G, Johnston JM, Evans GL, et al. Structure and inhibition of subunit Ⅰ of the anthranilate synthase complex of Mycobacterium tuberculosis and expression of the active complex. Acta Crystallogr D Biol Crystallogr, 2015, 71(Pt 11): 2297-2308. doi: 10.1107/S1399004715017216.
doi: 10.1107/S1399004715017216 URL |
[35] |
Negatu DA, Yamada Y, Xi Y, et al. Gut Microbiota Metabolite Indole Propionic Acid Targets Tryptophan Biosynthesis in Mycobacterium tuberculosis. mBio, 2019, 10(2): e02781-18. doi: 10.1128/mBio.02781-18.
doi: 10.1128/mBio.02781-18 |
[36] |
Sze MA, Tsuruta M, Yang SW, et al. Changes in the bacterial microbiota in gut, blood, and lungs following acute LPS instillation into mice lungs. PLoS One, 2014, 9(10): e111228. doi: 10.1371/journal.pone.0111228.
doi: 10.1371/journal.pone.0111228 URL |
[37] |
Wang J, Tian Z. How lung infection leads to gut injury. Oncotarget, 2015, 6(40): 42394-42395. doi: 10.18632/oncotarget.6470.
doi: 10.18632/oncotarget.6470 URL |
[38] |
白宇, 原林, 黄泳, 等. 经络的解剖学发现--筋膜学新理论. 世界科学技术--中医药现代化, 2010, 12(1): 20-24. doi: 10.3969/j.issn.1674-3849.2010.01.005.
doi: 10.3969/j.issn.1674-3849.2010.01.005 |
[39] |
王春雷, 原林, 王军 , 等. 人体筋膜重建经线与经典经线走行路线对比. 解剖学杂志, 2007, 30(3): 340-343. doi: 10.3969/j.issn.1001-1633.2007.03.022.
doi: 10.3969/j.issn.1001-1633.2007.03.022 |
[40] |
原林, 焦培峰, 唐雷 , 等. 中医经络理论的物质基础--结缔组织、筋膜和自体监控系统(筋膜学). 中国基础科学, 2005, 7(3): 44-47. doi: 10.3969/j.issn.1009-2412.2005.03.014.
doi: 10.3969/j.issn.1009-2412.2005.03.014 |
[41] | 赵吉平, 刘兵. 肺与大肠表里关系的经、穴互通基础研究. 北京中医药大学学报, 2010, 33(9):592-594. |
[42] | 曾祥国. 从粘液组织化学变化试论肺与大肠的阴阳表里关系. 四川医学, 1982, 3(3):129-132. |
[43] |
牛春雨, 李继承, 赵自刚 , 等. 肠系膜淋巴管结扎对大鼠急性肺损伤的影响. 中国病理生理杂志, 2006, 22(8):1566-1570. doi: 10.3321/j.issn:1000-4718.2006.08.025.
doi: 10.3321/j.issn:1000-4718.2006.08.025 |
[44] |
Tulic MK, Piche T, Verhasselt V. Lung-gut cross-talk: evidence, mechanisms and implications for the mucosal inflammatory diseases. Clin Exp Allergy, 2016, 46(4): 519-528. doi: 10.1111/cea.12723.
doi: 10.1111/cea.12723 pmid: 26892389 |
[45] |
Ahmadi Badi S, Khatami SH, Irani SH, et al. Induction Effects of Bacteroides fragilis Derived Outer Membrane Vesicles on Toll Like Receptor 2, Toll Like Receptor 4 Genes Expression and Cytokines Concentration in Human Intestinal Epithelial Cells. Cell J, 2019, 21(1): 57-61. doi: 10.22074/cellj.2019.5750.
doi: 10.22074/cellj.2019.5750 pmid: 30507089 |
[46] |
Schretter CE, Vielmetter J, Bartos I, et al. A gut microbial factor modulates locomotor behaviour in Drosophila. Nature, 2018, 563(7731): 402-406. doi: 10.1038/s41586-018-0634-9.
doi: 10.1038/s41586-018-0634-9 URL |
[47] |
Khan N, Mendonca L, Dhariwal A, et al. Intestinal dysbiosis compromises alveolar macrophage immunity to Mycobacterium tuberculosis. Mucosal Immunol, 2019, 12(3): 772-783. doi: 10.1038/s41385-019-0147-3.
doi: 10.1038/s41385-019-0147-3 URL |
[48] |
Huang Y, Yang Z, McGowan J, et al. Regulation of IgE Responses by γδ T Cells. Curr Allergy Asthma Rep, 2015, 15(4): 13. doi: 10.1007/s11882-015-0519-z.
doi: 10.1007/s11882-015-0519-z URL |
[49] |
Glanville N, Message SD, Walton RP, et al. γδT cells suppress inflammation and disease during rhinovirus-induced asthma exacerbations. Mucosal Immunol, 2013, 6(6): 1091-1100. doi: 10.1038/mi.2013.3.
doi: 10.1038/mi.2013.3 pmid: 23385428 |
[50] | 王蓓, 张文, 方邦江. 肠道菌群调控黏膜免疫与脓毒症的发病机制. 生命的化学, 2019, 39(6): 1153-1158. |
[51] |
Barreto ML, Pereira SM, Ferreira AA. BCG vaccine: efficacy and indications for vaccination and revaccination. J Pediatr (Rio J), 2006, 82(3 Suppl): S45-S54. doi: 10.2223/JPED.1499.
doi: 10.2223/JPED.1499 |
[52] |
Gopal R, Rangel-Moreno J, Slight S, et al. Interleukin-17-dependent CXCL 13 mediates mucosal vaccine-induced immunity against tuberculosis. Mucosal Immunol, 2013, 6(5): 972-984. doi: 10.1038/mi.2012.135.
doi: 10.1038/mi.2012.135 pmid: 23299616 |
[1] | DUAN Li-yao, LING Yan-bo, LIANG Yan, SHI Ying-chang, WANG Lan, ZHAO Guan-ren, LIU Jun, ZHENG Yue, WU Xue-qiong. Preliminary study on serum pharmacochemistry of Niubeixiaohe extract [J]. Chinese Journal of Antituberculosis, 2022, 44(5): 455-459. |
[2] | SUN Qing, LIAO Xin-lei, WANG Chen-qian, JIANG Guang-lu, DONG Ling-ling, WANG Fen, ZHAO Li-ping, HUANG Hai-rong, WANG Gui-rong. Characterization of rifampin resistance determining region mutations in tuberculosis patients with GeneXpert MTB/RIF positive RNA polymerase β subunit gene mutation [J]. Chinese Journal of Antituberculosis, 2022, 44(4): 349-353. |
[3] | CHEN Lei, GUO Hai-ping, PANG Yu, LIU Guang-fu, PAN Zhao-bao, HAN Shou-hua, CHENG Juan, LI Shan-shan. In vitro synergistic activities of GSK656 with amikacin against Mycobacterium abscessus [J]. Chinese Journal of Antituberculosis, 2022, 44(3): 234-238. |
[4] | CHEN Meng-meng, DONG Jing, SUN Qi, HUANG Mai-ling, DING Ze-yu, SHI Yu-ting, JIA Hong-yan, DU Bo-ping, WEI Rong-rong, XING Ai-ying, ZHANG Zong-de, PAN Li-ping. Diagnostic performance of differentially expressed miRNA identified by gene chip in discriminating tuberculous meningitis from viral meningitis [J]. Chinese Journal of Antituberculosis, 2022, 44(3): 264-272. |
[5] | ZHANG Li-juan, ZHANG Hua, WANG Xia-fang, SHI Mei-hua, FENG Yan-jun, ZHANG Jian-ping, TANG Pei-jun. The value of the ratio of tuberculosis specific antigen to CD4+ T cell count in the auxiliary diagnosis of AIDS complicated with pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2022, 44(3): 284-288. |
[6] | WANG Shao-hua, ZHAO Guo-lian, WANG Pei, TAN Xiao-wen, CUI Xiao-li, KANG Lei, DANG Li-yun. Analysis of inconsistency between genotypic and phenotypic results of Mycobacterium tuberculosis rifampicin susceptibility test [J]. Chinese Journal of Antituberculosis, 2022, 44(2): 169-173. |
[7] | YI Yi-hang, YU Rong, SHI Guo-min, MA Xiao-hua, XIAO Si-fang, SHUI Jian, FAN Ren-hua, XIANG Yan-gen. Analysis of the composition and phenotypes of intestinal flora in primary bacteriologically-confirmed pulmonary tuberculosis patients based on high-throughput sequencing of 16S rRNA V4 region [J]. Chinese Journal of Antituberculosis, 2021, 43(9): 939-946. |
[8] | YU Xia, REN Ru-yan, WEN Shu-an, LIANG Qian, DONG Ling-ling, HUANG Hai-rong. Evaluation of in vitro antibacterial effects of 13 antibiotics against rapidly growing mycobacteria [J]. Chinese Journal of Antituberculosis, 2021, 43(9): 947-951. |
[9] | MA Ting-ting, REN Fei, MA Jin-bao, YANG Han. Resistance of prothionamided and sodium aminosalicylate among isoniazid resistant pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2021, 43(9): 961-964. |
[10] | ZHENG Hui-wen, SHEN A-dong. The diagnosis and treatment of non-tuberculous mycobacterium disease in children [J]. Chinese Journal of Antituberculosis, 2021, 43(9): 979-982. |
[11] | XIA Hui, ZHAO Yan-lin. Inspiration of the WHO Updated on the use of nucleic acid amplification tests to detect TB and drug-resistant TB: rapid communication [J]. Chinese Journal of Antituberculosis, 2021, 43(8): 761-765. |
[12] | WANG Quan, MA Rui-ying, YANG Ting, ZHANG Ya-li, XU Miao, SA Yu-ling, CHEN Qing-bo. Application value of thermostatic microfluidic system in detection and identification of Mycobacterium tuberculosis complex and nontuberculous mycobacteria [J]. Chinese Journal of Antituberculosis, 2021, 43(8): 817-820. |
[13] | YANG Ting-ting, GAO Qian. The tuberculosis drug-resistance and transmission surveillance network based on whole genome sequencing data [J]. Chinese Journal of Antituberculosis, 2021, 43(7): 645-648. |
[14] | ZHAO Guo-lian, TAN Xiao-wen, CUI Xiao-li, DANG Li-yun. Analysis of gene polymorphism of Mycobacterium tuberculosis with negative MPT64 antigen in culture filtrate [J]. Chinese Journal of Antituberculosis, 2021, 43(7): 659-663. |
[15] | LI Ai-fang, TAN Xiao-wen, CUI Xiao-li, KANG Lei, DANG Li-yun, ZHANG Yao-hui, YANG Han. Application value of fluorescence PCR melting curve method in the identification of non-tuberculous mycobacteria [J]. Chinese Journal of Antituberculosis, 2021, 43(7): 664-669. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||